Determinant Effects of Average Fasting Plasma Glucose on Mortality in Diabetic End-Stage Renal Disease Patients on Maintenance Hemodialysis

Determinant Effects of Average Fasting Plasma Glucose on Mortality in Diabetic End-Stage Renal Disease Patients on Maintenance Hemodialysis

Diabetic kidney disease is an increasingly frequent cause of end-stage renal disease. However, mixed results were shown between glycated hemoglobin and mortality. Methods: We used the average fasting plasma glucose (FPG) levels to predict mortality rates in long-term hemodialysis patients. We enroll...

Full description

Bibliographic Details
Main Authors: Yi-Chun Lin, Yen-Chung Lin, Hsi-Hsien Chen, Tzen-Wen Chen, Chih-Cheng Hsu, Mai-Szu Wu
Format: Article
Language:English
Published: Elsevier 2017-01-01
Series:Kidney International Reports
Subjects:
end-stage renal disease
fasting blood glucose
hemodialysis
mortality
renal replacement therapy
Online Access:http://www.sciencedirect.com/science/article/pii/S2468024916300729

Internet

http://www.sciencedirect.com/science/article/pii/S2468024916300729

Similar Items